These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16251880)

  • 21. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland].
    Iushkov PV; Antonova SS; Bartolazzi A
    Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
    Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 immunodetection may improve cytological diagnosis of occult papillary thyroid carcinoma.
    Pisani T; Vecchione A; Giovagnolii MR
    Anticancer Res; 2004; 24(2C):1111-2. PubMed ID: 15154632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of fine needle aspiration biopsy with and without the use of tumor markers in cytologically indeterminate thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Coll Antropol; 2010 Mar; 34(1):53-7. PubMed ID: 20432733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules.
    Gasbarri A; Marchetti C; Iervasi G; Bottoni A; Nicolini A; Bartolazzi A; Carpi A
    Biomed Pharmacother; 2004; 58(6-7):356-9. PubMed ID: 15271416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
    Hayashi N; Kitaoka M
    Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies.
    Inohara H; Segawa T; Miyauchi A; Yoshii T; Nakahara S; Raz A; Maeda M; Miyoshi E; Kinoshita N; Yoshida H; Furukawa M; Takenaka Y; Takamura Y; Ito Y; Taniguchi N
    Biochem Biophys Res Commun; 2008 Nov; 376(3):605-10. PubMed ID: 18809382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
    Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low galectin-3 capacity to discriminate thyroid lesions].
    De-León-Mazariegos R; Canedo-Patzi M; Pérez-Enríquez B; Candanedo-Gonzalez F; Saqui-Salces M; Gamboa-Domínguez A; Rull-Rodrigo JA
    Rev Invest Clin; 2004; 56(5):623-8. PubMed ID: 15776867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma.
    Papotti M; Volante M; Saggiorato E; Deandreis D; Veltri A; Orlandi F
    Eur J Endocrinol; 2002 Oct; 147(4):515-21. PubMed ID: 12370115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration.
    Faroux MJ; Theobald S; Pluot M; Patey M; Menzies D
    Pathol Res Pract; 1997; 193(10):705-12. PubMed ID: 9505263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
    Feilchenfeldt J; Tötsch M; Sheu SY; Robert J; Spiliopoulos A; Frilling A; Schmid KW; Meier CA
    Mod Pathol; 2003 Nov; 16(11):1117-23. PubMed ID: 14614051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
    Torregrossa L; Faviana P; Filice ME; Materazzi G; Miccoli P; Vitti P; Fontanini G; Melillo RM; Santoro M; Basolo F
    Thyroid; 2010 May; 20(5):495-504. PubMed ID: 20450430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
    Mataraci EA; Ozgüven BY; Kabukçuoglu F
    Pol J Pathol; 2012 Mar; 63(1):58-64. PubMed ID: 22535608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study.
    Franco C; Martínez V; Allamand JP; Medina F; Glasinovic A; Osorio M; Schachter D
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):211-5. PubMed ID: 19384080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions.
    Aiad HA; Kandil MA; Asaad NY; El-Kased AM; El-Goday SF
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):36-46. PubMed ID: 19847280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
    Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M
    Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.